Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies

Abstract In children and adolescents the Second Generation Antipsychotics (SGAs) represent the class of psychotropic drugs whose use has grown more significantly in recent years: they are primarily used for treatment of patients with disruptive behavior disorders, mood disorders and pervasive develo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European neuropsychopharmacology 2011-08, Vol.21 (8), p.600-620
Hauptverfasser:	Zuddas, Alessandro, Zanni, Roberta, Usala, Tatiana
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Aripiprazole Bipolar disorder Bipolar Disorder - drug therapy Child Conduct disorder Developmental Disabilities - drug therapy Double-Blind Method Female Humans Internal Medicine Male Olanzapine Pervasive developmental disorders Psychiatry Psychotic Disorders - drug therapy Quetiapine Randomized Controlled Trials as Topic Risperidone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!